IP Verse

Hbv Antisense Inhibitors

PatentPatent Analysis

EP2512491

GLAXO GROUP
Application Number
EP10824199A
Filing Date
Oct 15, 2010
Status
Revoked
Apr 17, 2020
Grant Date
Oct 11, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3578169B1
EP3335707B1
EP1907037B2

Bibliography

The patent EP2512491B1 was granted to Glaxo Group on Oct 11, 2017 following the initial filing on Oct 15, 2010 under the application number EP10824199A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ROCHE INNOVATION CENTER COPENHAGENJul 10, 2018 -

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents